Bone osteosarcoma: genes and variants
Explore variant evidence for Bone osteosarcoma across 3 analyzed proteins (TP53, CHEK2, RB1). Linked ClinVar records include 5 pathogenic or likely pathogenic variants, 41 variants of uncertain significance and 27 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Bone osteosarcoma
TP53: Cellular tumor antigen p53
It coordinates transcriptional responses to DNA damage and other cellular stresses, promoting cell-cycle arrest, senescence, DNA repair, or apoptosis when appropriate. Loss of this tumor-suppressive control is one of the most common events in cancer, while germline pathogenic variants cause Li-Fraumeni syndrome.
3 ClinVar pathogenic / likely pathogenic and 4 uncertain variants in TP53 have source records linked to Bone osteosarcoma. Association strength is not clinical gene validity.
CHEK2: Serine/threonine-protein kinase Chk2
It propagates DNA-damage checkpoint signals to proteins controlling cell-cycle arrest, repair, and apoptosis. Germline loss-of-function variants confer moderate cancer susceptibility, especially for breast cancer, while risk estimates depend on the specific allele and family context.
2 ClinVar pathogenic / likely pathogenic and 55 uncertain variants in CHEK2 have source records linked to Bone osteosarcoma. Association strength is not clinical gene validity.
RB1: Retinoblastoma-associated protein
It restrains E2F-dependent transcription and prevents inappropriate G1-to-S cell-cycle progression until proliferative signals are appropriate. Loss of function is a fundamental cancer-driving event, while germline pathogenic variants cause hereditary retinoblastoma and increase risk of additional tumors.
0 ClinVar pathogenic / likely pathogenic and 9 uncertain variants in RB1 have source records linked to Bone osteosarcoma. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Bone osteosarcoma
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| TP53 R267W | 267 | DNA binding | Pathogenic / likely pathogenic (★★) |
| CHEK2 L236P | 236 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| TP53 R273L | 273 | DNA binding | Pathogenic / likely pathogenic (★★) |
| TP53 R282P | 282 | DNA binding | Pathogenic / likely pathogenic (★★) |
| CHEK2 A17S | 17 | Pathogenic / likely pathogenic |
Same protein, different disease
- Li-Fraumeni syndrome also has ClinVar records linked to TP53 variants; they fall mostly in different places as the Bone osteosarcoma variants (188 pathogenic / likely pathogenic).
- Adrenocortical carcinoma, hereditary also has ClinVar records linked to TP53 variants; they fall mostly in different places as the Bone osteosarcoma variants (23 pathogenic / likely pathogenic).
- Acute myeloid leukemia also has ClinVar records linked to TP53 variants; they fall mostly in different places as the Bone osteosarcoma variants (6 pathogenic / likely pathogenic).
- Hereditary breast ovarian cancer syndrome also has ClinVar records linked to TP53 variants; they fall mostly in different places as the Bone osteosarcoma variants (6 pathogenic / likely pathogenic).
- Hereditary breast cancer also has ClinVar records linked to TP53 variants; they fall partly in the same places as the Bone osteosarcoma variants (5 pathogenic / likely pathogenic).
- Hereditary breast cancer also has ClinVar records linked to CHEK2 variants; they fall mostly in different places as the Bone osteosarcoma variants (3 pathogenic / likely pathogenic).
Diseases related to Bone osteosarcoma
- Li-Fraumeni syndrome, also linked to CHEK2 and TP53
- Hereditary breast cancer, also linked to CHEK2 and TP53
- Hereditary breast ovarian cancer syndrome, also linked to CHEK2 and TP53
- Colorectal cancer, also linked to CHEK2 and TP53
- Gastric cancer, also linked to CHEK2 and TP53
- Urinary bladder cancer, also linked to RB1 and TP53
- Lung adenocarcinoma, also linked to RB1 and TP53
- Hepatocellular carcinoma, also linked to RB1 and TP53
- Breast and/or ovarian cancer, also linked to CHEK2 and TP53
- Prostate cancer, hereditary, also linked to CHEK2 and TP53
- Lynch syndrome, also linked to CHEK2
- Acute myeloid leukemia, also linked to TP53
Frequently asked questions
Which genes have records linked to Bone osteosarcoma?
This view contains 3 analyzed proteins: TP53, CHEK2, RB1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 5 pathogenic or likely pathogenic variants, 41 variants of uncertain significance and 27 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 73 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center